Role of Suppression of Tumorigenecity (ST2) in Pulmonary Vascular Complications of Liver Disease

Authors :: Kari E. Roberts
Anna R. Hemnes
Grace Lin
S.M. Kawut
Gustavo A. Heresi
Jae K. Oh
Michael B. Fallon
Michael J. Krowka
Paul D. Scanlon
Karen L. Krok
Hilary M. DuBrock
Kimberly A. Forde
Todd M. Bull
Jasleen Minhas
Nadine Al-Naamani
Eric D. Austin
Sonja Bartolome
Carl D. Mottram
M. Patel
Source :: D56. X MARKS THE SPOT: NEW BIOMARKERS IN PAH.
Publication Year :: 2019
Publisher :: American Thoracic Society, 2019.

Subjects :: medicine.medical_specialty
Liver disease
business.industry
Internal medicine
medicine
business
medicine.disease
Gastroenterology

Tools